Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-24-083478
Filing Date
2024-10-01
Accepted
2024-10-01 06:00:05
Documents
4

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT ea0203318-02.htm POS AM 709733
2 CONSENT OF SOMEKH CHAIKIN (MEMBER FIRM OF KPMG INTERNATIONAL), INDEPENDENT REGIS ea020331802ex23-1_neurosense.htm EX-23.1 2320
3 GRAPHIC tneuro_logo.jpg GRAPHIC 117138
4 GRAPHIC timage_001.jpg GRAPHIC 449734
  Complete submission text file 0001213900-24-083478.txt   1494142
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-273375 | Film No.: 241341114
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)